Entera Bio Ltd.
ENTX
$1.21
$0.010.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -76.80% | 25.25% | 191.23% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -76.80% | 25.25% | 191.23% | -- |
| Cost of Revenue | -100.00% | -75.58% | 37.78% | 245.83% | -- |
| Gross Profit | -100.00% | -100.00% | -100.00% | -100.00% | -- |
| SG&A Expenses | 3.17% | 8.44% | 8.21% | 19.29% | 16.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.30% | 18.48% | 17.59% | 24.58% | 17.94% |
| Operating Income | -23.98% | -20.28% | -17.51% | -23.47% | -15.39% |
| Income Before Tax | -22.82% | -20.07% | -17.31% | -24.46% | -16.00% |
| Income Tax Expenses | -- | -- | -- | -51.72% | -51.72% |
| Earnings from Continuing Operations | -22.65% | -19.89% | -17.47% | -24.20% | -15.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.65% | -19.89% | -17.47% | -24.20% | -15.78% |
| EBIT | -23.98% | -20.28% | -17.51% | -23.47% | -15.39% |
| EBITDA | -24.20% | -20.55% | -17.76% | -23.78% | -15.65% |
| EPS Basic | -1.67% | 2.21% | 6.22% | 2.36% | 9.80% |
| Normalized Basic EPS | -1.80% | 2.09% | 6.33% | 2.08% | 9.56% |
| EPS Diluted | -1.67% | 2.21% | 6.22% | 2.36% | 9.80% |
| Normalized Diluted EPS | -1.80% | 2.09% | 6.33% | 2.08% | 9.56% |
| Average Basic Shares Outstanding | 20.19% | 22.58% | 25.06% | 26.27% | 26.84% |
| Average Diluted Shares Outstanding | 20.19% | 22.58% | 25.06% | 26.27% | 26.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |